The therapy was used by Tudor Vagaonescu, MD, PhD, associate professor of cardiology at Rutgers Robert Wood Johnson Medical School and medical director of the hospital’s Cardiac Catheterization Laboratories, to treat a 77-year-old patient whose artery had repeatedly narrowed after several previous angioplasty treatments with drug-eluting stents.
“In this patient’s particular case, medical literature indicated that this treatment gave her the best option for a successful outcome,” Dr. Vagaonescu said in the release. “This breakthrough therapy can provide new hope for patients who experience these recurrences following their initial treatment. It has the potential to reduce hospital readmissions and improve the quality of life for patients diagnosed with in-stent restenosis (narrowing of prior implanted stents).”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
